Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
JAMA Neurology|August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson diseaseJu-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.
Parkinsonism & Related Disorders|February 11, 2019
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, et al.
Nature Aging|April 28, 2023
RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson's diseaseDavid W Craig, Elizabeth Hutchins, Ivo Violich, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmiaDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Neurology|July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior DisorderDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 25, 2018
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative CohortTanya Simuni, Andrew Siderowf, Shirley Lasch, et al.
NPJ Parkinson'S Disease|February 11, 2023
A proteogenomic view of Parkinson's disease causality and heterogeneitySergio Kaiser, Luqing Zhang, Brit Mollenhauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease ProgressionBrit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohortKenneth Marek, Sohini Chowdhury, Andrew Siderowf, et al.
Acta Neuropathologica|March 30, 2016
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative studyJu-Hee Kang, Brit Mollenhauer, Christopher S Coffey, et al.
Pageof 4